Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Vanda Pharmaceuticals, Inc. to

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of
$100,000 Investing in Vanda Pharmaceuticals, Inc. to Contact the Firm -- VNDA

NEW YORK, Aug. 9, 2013 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading
national securities law firm, reminds investors in Vanda Pharmaceuticals, Inc.
("Vanda" or the "Company") (Nasdaq:VNDA) of the August 26, 2013 deadline to
seek the role of lead plaintiff in a federal securities class action lawsuit
filed against the Company and certain executives.

A complaint has been filed on behalf of all persons who purchased Vanda
securities between December 18, 2012 and June 18, 2013 (the "Class Period").

The complaint alleges that the Company and its executives violated federal
securities laws with respect to its disclosures concerning business,
operational, and compliance policies. Specifically, the action alleges that
Vanda misled investors regarding the efficacy of tasimelteon, one of the
Company's products, by manipulating aspects of tasimelteon's primary Phase III
study.

The Street published an article on June 19, 2013, questioning the efficacy of
Vanda's clinical trial procedure. Following this news, the Company's shares
dropped $2.41 or over 22%.

Request more information now by clicking here: www.faruqilaw.com/VNDA. There
is no cost or obligation to you.

Take Action

If you invested in Vanda's stock or options between December 18, 2012 and June
18, 2013 and would like to discuss your legal rights, visit
www.faruqilaw.com/VNDA. You can also contact us by calling Richard Gonnello or
Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending
an e-mail to rgonnello@faruqilaw.com or fmcconville@faruqilaw.com. Faruqi &
Faruqi, LLP also encourages anyone with information regarding Vanda's conduct
to contact the firm, including whistleblowers, former employees, shareholders
and others.

Attorney Advertising.The law firm responsible for this advertisement is
Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or
predict a similar outcome with respect to any future matter.We welcome the
opportunity to discuss your particular case.All communications will be
treated in a confidential manner.

CONTACT: FARUQI & FARUQI, LLP
         369 Lexington Avenue, 10th Floor
         New York, NY 10017
         Attn:  Richard Gonnello, Esq.
         rgonnello@faruqilaw.com
         Francis McConville, Esq.
         fmcconville@faruqilaw.com
         Telephone: (877) 247-4292 or (212) 983-9330